Children with muscular dystrophy who receive treatments developed through research
programs funded by MDA would represent __________ for this charitable organisation.
A)target publics
B)target population
C)general publics
D)focus groups
E)client publics
programs funded by MDA would represent __________ for this charitable organisation.
A)target publics
B)target population
C)general publics
D)focus groups
E)client publics